168 related articles for article (PubMed ID: 11572763)
1. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers.
Tanaka K; Nishioka J; Kato K; Nakamura A; Mouri T; Miki C; Kusunoki M; Nobori T
Jpn J Cancer Res; 2001 Sep; 92(9):952-8. PubMed ID: 11572763
[TBL] [Abstract][Full Text] [Related]
2. Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer.
Hernando E; Orlow I; Liberal V; Nohales G; Benezra R; Cordon-Cardo C
Int J Cancer; 2001 Jul; 95(4):223-7. PubMed ID: 11400114
[TBL] [Abstract][Full Text] [Related]
3. Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers.
Imai Y; Shiratori Y; Kato N; Inoue T; Omata M
Jpn J Cancer Res; 1999 Aug; 90(8):837-40. PubMed ID: 10543255
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis.
Jeong SJ; Shin HJ; Kim SJ; Ha GH; Cho BI; Baek KH; Kim CM; Lee CW
Cancer Res; 2004 Dec; 64(23):8666-73. PubMed ID: 15574775
[TBL] [Abstract][Full Text] [Related]
5. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
[TBL] [Abstract][Full Text] [Related]
6. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers.
Takahashi T; Haruki N; Nomoto S; Masuda A; Saji S; Osada H; Takahashi T
Oncogene; 1999 Jul; 18(30):4295-300. PubMed ID: 10439037
[TBL] [Abstract][Full Text] [Related]
7. Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint.
Kim HS; Park KH; Kim SA; Wen J; Park SW; Park B; Gham CW; Hyung WJ; Noh SH; Kim HK; Song SY
Mutat Res; 2005 Oct; 578(1-2):187-201. PubMed ID: 16112690
[TBL] [Abstract][Full Text] [Related]
8. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
9. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
[TBL] [Abstract][Full Text] [Related]
10. MAD2 as a key component of mitotic checkpoint: A probable prognostic factor for gastric cancer.
Wang L; Yin F; Du Y; Du W; Chen B; Zhang Y; Wu K; Ding J; Liu J; Fan D
Am J Clin Pathol; 2009 Jun; 131(6):793-801. PubMed ID: 19461085
[TBL] [Abstract][Full Text] [Related]
11. [Expression of human spindle mitosis arrest deficiency gene in spontaneous abortion embryo tissues].
Cai Y; Wang J; Yuan TX; Shi Q; Weng YG; Wang YX; Jiang HY; Liu ZJ
Zhonghua Fu Chan Ke Za Zhi; 2008 May; 43(5):346-51. PubMed ID: 18953867
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
[TBL] [Abstract][Full Text] [Related]
13. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
14. Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells.
Sze KM; Ching YP; Jin DY; Ng IO
J Biomed Sci; 2004; 11(6):920-7. PubMed ID: 15591789
[TBL] [Abstract][Full Text] [Related]
15. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
17. Characterization of regions in hsMAD1 needed for binding hsMAD2. A polymorphic change in an hsMAD1 leucine zipper affects MAD1-MAD2 interaction and spindle checkpoint function.
Iwanaga Y; Kasai T; Kibler K; Jeang KT
J Biol Chem; 2002 Aug; 277(34):31005-13. PubMed ID: 12042300
[TBL] [Abstract][Full Text] [Related]
18. Expression of SNCG, MAP2, SDF-1 and CXCR4 in gastric adenocarcinoma and their clinical significance.
Zheng S; Shi L; Zhang Y; He T
Int J Clin Exp Pathol; 2014; 7(10):6606-15. PubMed ID: 25400739
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer.
Liu N; Zhang LH; Du H; Hu Y; Zhang GG; Wang XH; Li JY; Ji JF
Ann Surg Oncol; 2010 Oct; 17(10):2628-39. PubMed ID: 20383661
[TBL] [Abstract][Full Text] [Related]
20. MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour.
Fung MK; Cheung HW; Wong HL; Yuen HF; Ling MT; Chan KW; Wong YC; Cheung AL; Wang X
Biochim Biophys Acta; 2007 Jun; 1773(6):821-32. PubMed ID: 17467818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
